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Abstract.  To carry out a detailed comparison of the 
roles of integrin/51 and/55 cytoplasmic domains, we 
expressed both wild type/51 and chimeric/svs con- 
structs in CHO cells. In the latter, the cytoplasmic do- 
main of/51 was replaced with that of/55.  The human 
/51 and/5~s constructs appeared at similar levels at the 
cell surface (mostly as ¢x5/51 heterodimers) and con- 
tributed equally to CHO cell adhesion to fibronectin. 
However,/st but not/sv~ localized to focal adhesion- 
like structures when CHO cells were spread on 
fibronectin. Furthermore, only the/51-CHO cells 
showed increased proliferation in response to fibronec- 
tin plus an integrin-activating anti-B1 antibody, and 
showed increased appearance of 32p-labeled protein 
(p90) that correlated with proliferation. In sharp con- 
trast, the/5~5-CHO cells were notably more migratory 
than/5~-CHO cells in a transwell haptotactic migration 
assay.  These results indicate that the/51  and/55 integrin 
subunlt cytoplasmic domains can translate similar 
adhesive information into highly contrasting subse- 
quent events. Thus, we have established that "inside- 
out" and "outside-in" integrin signaling pathways are 
regulated by fundamentally distinct mechanisms. In 
addition, we suggest that the same properties of the/51 
cytoplasmic domain that promote recruitment to visi- 
ble focal adhesion-like structures may also be con- 
ducive to cell proliferation. Conversely, the properties 
of the/55 tail that make it less likely to localize into 
focal adhesion-like structures may contribute to en- 
hanced cell migration. 
T 
HE 21 transmembrane o~/5 heterodimers in the integrin 
family of  cell adhesion receptors (26, 34) play key roles 
in two-way signaling  across  the membrane. The di- 
verse cytoplasmic  domain sequences within the various inte- 
grin o~ and /5  subunits  are particularly important in this 
regard. 
In a process known as ~inside-out signaling; constitutive 
cellular signals or agonist-triggered signals act through inte- 
grin cytoplasmic  domains to regulate'  the ligand-binding 
properties of the extracellular domains (23, 76).  Experi- 
ments involving deletions and point mutations within the cy- 
toplasmic domains of/51 (25),/52 (31, 32), and/53 (12) have 
focused attention  on a  few conserved residues in each of 
these subunits  as  being most critical for control of cell 
adhesion. 
Conversely, external ligand binding may cause changes in 
cytoplasmic domains (outside-in signaling) associated with 
a diversity of postligand binding events, such as cell spread- 
ing,  migration, differentiation,  focal  adhesion  formation, 
and gene induction (9, 13, 34, 43). Thus far, despite differ- 
ences in/5  suhunit  cytoplasmic domain sequences,  many 
integrin-mediated signaling events appear to be rather non- 
specific. For example, several different integrins are able to 
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cause calcium flux (37, 58, 60, 65, 70, 86), a rise in intracel- 
lular pH (36, 45, 71, 72), and activation of p125  ~AK (24, 42, 
47).  For  some postligand  binding  events,  resulting  from 
outside-in signaling through integrins,  it is clear that cyto- 
plasmic domains do play specific roles.  For example, chi- 
meric o~ chain constructs were used to demonstrate that the 
o: and o~ cytoplasmic domains differed from the ~  cyto- 
plasmic domain with respect to collagen gel contraction and 
cell migration mediated by ~x2/51 (VLA-2) (9). 
An obvious assumption has been that the subcellular local- 
ization ofintegrins plays a key role in determining  their func- 
tions. For example, integrin clustering may make an impor- 
tant contribution  to cell adhesion O0).  In highly spread 
cells, a very prominent type of integrin cluster called a focal 
adhesion complex has been studied in great detail. A variety 
of studies involving deletions (25, 49, 64, 75), chimeras (21, 
43), alternatively  spliced/51 (4),  and point mutations (64) 
have established that the/51 cytoplasmic domain controls/51 
integrin localization to focal adhesions.  Many of the cyto- 
plasmic domain residues critical for focal adhesion localiza- 
tion (64) are shared by several other/5 subunits, thus explain- 
ing why the cytoplasmic domains of/51 and/53 have similar 
capability  to localize to focal adhesions  (74). Despite this 
abundance of  background information, the functional conse- 
quences of  having integrins that differ in their ability to local- 
ize to focal adhesions has only begun to be explored (68). 
Among the integrin /51, /52, /53, /57, and/55 cytoplasmic do- 
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sequence  (61,  88).  Perhaps  related  to this,  the ceil5 and 
o~f13 integrins appear to differ in terms of localization to fo- 
cal adhesions  and contribution to cell migration  (44,  82). 
However,  these  reported  functional  differences  between 
o~+~5 and ce~3 have  not yet been mapped to  specific  do- 
mains;  (e.g.,  ~  chain cytoplasmic domains). 
Here,  we have expressed in CHO cells cDNA constructs 
coding  for human fit and a chimeric/3~,5 subunit,  in which 
the cytoplasmic domain of fl~ was replaced with that of fls. 
These have enabled us to carry out highly  controlled and 
detailed comparative studies  showing that (a) the ~t and B5 
cytoplasmic domains differed dramatically  in their control of 
integrin  subceUular localization,  and (b) that differences in 
subeeUular localiTation were associated with differences  in 
integrin-dependent  proliferation  and migration  but not cell 
adhesion.  Thus, mechanisms  for cytoplasmic tail control of 
cell adhesion (inside-out signaling) are fundamentally  differ- 
ent from mechanisms  for control of diverse postadhesion 
events (outside-in  signaling). 
Materials and Methods 
Cells, Tmnsfections, and Cell Culture 
CHO cells negative  for the dihydrofolate  reductase gene (dhfr-)  t  were 
grown in MEM a + medium with 10% FCS, and then switched to MEM cx- 
with 10% dialyzed FCS (JRH Biosciences,  Lenexa, KS) after transfecfion. 
The dhfr  + IO01 vector (40) was kindly provided by Dr.  M. Rosa, Biogen 
Co. (Cambridge,  MA). The pECE vector containing the ft insert has been 
previously described (22). A fragment corresponding to the f5 cytoplas- 
mic domain was obtained from mRNA (from the CCL-228 carcinoma line) 
by reverse transcription PCR. In one of the oligonnoleotide  primers used 
for PCR, a single mismatch was incorporated to cxe~te a HindIII site at the 
carboxy-terminal  side of the transmembrane region. At this site, coding for 
the amino acids Lys and Leu, AAGCTG_  was convened to AAGCT!" (a si- 
lent mutation).  The  entire PCR-derived f5  insert was  subcloned into 
pBinescript (Stratngene, La Jolla, CA) and sequenced.  The ft cytoplasmic 
domain was removed from the pECE vector using HindIII/XbaI sites (just 
after the transmembrane and in the 3' polylinker region, respectively)  and 
replaced with the fs cytoplasmic domain also excised (from pBinescript) 
using ~  and XbaI sites. The resulting ftts chimera had the carboxy- 
terminal sequence...  GLALLAIWKLLVTIHDRREFAKFQSERSRAR- 
YEMASNPLYRKPISTHTVDFrFNKFNKGTVD  with  the  underlined 
portion derived from fs, and the rest of the molecule derived from ft. 
For tmnsfecfion,  CHO celis were washed once in PBS/EDTA,  twice in 
MEM c~  +, and then resuspended in serum-free MEM a + media with two 
different purified plasmids (I ~tg iO01 dhfr  + and I0/tg ft-pECE or fus- 
pECE).  After pulsing with a  gene pulser (Bio-Rad  Laboratories, Rich- 
mond, CA) (set at 280 V and 960 ~tF), cells were resuspended in MEM 
c,  + medium, with 10% FCS. After 5 d, the cells were grown in MEM-a-, 
and after an additional 8-10 d,  the cells were stained with the anti-Bit 
monoclonal antibody A-1A5, and then sorted using a flow cytometer (Epics; 
Coulter Corp., Hiaieah, FL) to select the 5% most positive population. 
These cells were grown in the presence of methotrexate (Aldrich Chemical 
Co., Mllweukee,  WI) as described (22) to amplify fx and fu5 expression, 
and several additional rounds of amplification and sorting were carried out 
until human ft and ft/5 expression levels were ~10 times higher tban ham- 
ster ft- Control cell lines include CHO (untrausfected)  and CHO-MTX. 
The latter was transfected with IO01 dhfr  + plasmid plus f5 eDNA in the 
pRc/CMV vector 0nvitrogen, San Diego,  CA),  but during methotrexate 
(MTX) amplification (in parallel with ft and fl/5 amplification),  the f~ ex- 
pression was lost. 
Abbreviations  used in this paper: dhfr, dihydmfolate  reductase gene; FN, 
fibmnectin;  MTT,  3-[4,5-dimethylthazol-2-yl]-2,5-diphenyltetrazollum; 
MTX, methotmxate. 
Antibodies and Extracellular Matrix (ECM) Proteins 
The monoclonal antibodies used were:  A-1A5 (28), TS2fl6 (27), and 4134 
(52), all anti-human Bt; PB1, anti-hamster #Bx (7); 7E2, anti-bamster Bt 
(18); B1E5, anti-# cross-reactive  with human and hamster (83); and 1(38, 
anti-Bs cross-reactive  with human and hamster (59). Rabbit polyclonal sera 
to f5 (61) and #  (35) cytoplasmic domain peptides were previously  de- 
scribed. Both fibronectin  and vitronectin were purchased from Tellos Phar- 
maceuticals (La Julla, CA), and pronectin, a synthetic Arg-Gly-Asp--con- 
taming mauix protein, was obtained from Promega Corp.  (Madison, WI). 
A mouse monoclonal antibody to the cytoskeletal protein talin was obtained 
from  Sigma  Imraunochemiculs  (St.  Louis,  MO),  and  the  mouse  an- 
tiphosphotyrosine antibody 4G10 (16) was a gift from Dr.  Brian Druker 
(Dana-Farber Cancer Institute). 
Flow Cytometry 
Cells were incubated in PBS containing 1% BSA (Sigma Immunochemi- 
cals) and 5 % human serum (Gibco Laboratories, Grand Island, NY) for 
30 min on ice, then washed three times in the same solution. Subsequently, 
cells (2-3  ×  105) were incubated with purified antibodies (1-10 ttg/mi) or 
ascites (diluted 1:100) for 45 rain, and then washed three times in PBS con- 
taining 1% BSA, and treated with goat anti-mouse IgG coupled to fluores- 
cein (Cappel Laboratories, Cochranville, PA) for 45 mitt on ice. After three 
washes, cells were resuspended in PBS and analyzed using a flow cytometer 
(FACScan°;  Becton  Dickinson  Immunocytometry  Systems,  Mountain 
View, CA). 
RadiolabeUng and Immunoprecipitation 
Cells were surface labeled with t2~I  using lactoperoxidase  or metabolically 
labeled using [3SS]methionine and cysteine, and then lysed in the presence 
of 1% NP-40 (Calbiochem Corp., La Jolla, CA) and protease inhibitors 
(PMSF, aprotinin, lenpeptin were all from Sigma lmmunochemicals). Im- 
munoprecipitations were  performed  using  protein  A-Sepbarose  beads 
(Pharmacia Fine Chemicals, Piscataway, NJ) previously incubated with un- 
labeled cell extract to prevent nouspeciflc binding of radiolabeled material. 
Labeled extracts were precleared by incubation  with normal mouse or rabbit 
serum, followed by Staphylococcus  aureus Cowan  I  (Pansorbin; Calbio- 
chem Corp.). Immunoprecipitatious were performed using monoclunal an- 
tibodies at 2/~g/mi (purified) or diluted 1:100 (ascites), with 3  ×  106 cpm 
of radiulabaled cell extract per sample. Rat anti-mouse IgG mAb 187.1 (87) 
was added to optimize binding to protein A-Sepbarose. Incubations lasted 
from 30 min to overnight, and then samples were washed three times in 1% 
NP-40 and analyzed by SDS-PAGE using 6-8% acrylamide gels under non- 
reducing conditions, unless otherwise stated. 
Adhesion and Migration Assays 
Cell adhesion assays  were performed in 96-well  microtiter plates (Flow 
Laboratories Inc., McLean, VA) coated overnight at 4°C with extracellular 
matrix protein ligands,  followed by 0.19[ BSA (for 30 min at 37°C) added 
to block nonspecific  adhesion. Cells were labeled by incubation with the 
fluorescent dye BCECF (Molecular Probes, Inc., Eugene, OR) for 20 rain. 
After washing two times with PBS, 5xl04 of the labeled cells were added 
in tripficate to plates in the presence or absence of antibodies (1 ~tg/ml or 
50 ~d of hybridoma supernatant) and incubated for 20 rain at 37°C, followed 
by three washes with RPMI medium containing 0.1% BSA. Cells remaini~ 
attached to the plate were analyzed usin8 a  fluorescence  concentration 
analyzer (IDEXX Co., Portland, ME). Results are reported as the mean + 
1 SD. 
Haptotactic migration assays were performed as described (44), using 
Boyden chambers (Trauswell; Costar Corp., Cambridge, MA), containing 
membranes with 6.5 mm diameter,  10 van thickness, and 8 van pore size. 
Lower  faces  of the membranes were coated overnight with fibronectin, 
vitronecfin,  or  pronectin  (Promege  Corp.)  at  3  /tg/mi  in  serum-free 
medium. Cells were labeled with [3SS]methionine for 3 h, washed,  and 
then incubated for 10-15 rain on ice with mAb PBI to block hamRter #ft 
function. In some experiments, cells were also preincubated with TS2/16 
(1/~g/mi). FOr migration assays, the upper and lower faces of the membrane 
were equilibrated in ,~- MEM  with 2%  FCS,  and then the cells were 
placed in the upper compartment (50,000/chamber), and incubated at 37°C 
for 1-12 h. After extensive washing,  membranes were removed and ana- 
lyzed by liquid scinti~on counting, and the mean of tripficate values for 
35S cpm representing each experimental condition was calculated.  No ra- 
dioactivity above background was detected in the upper part of  the chambers 
after washing. 
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Cells were detached from tissue culture dishes using 2.5 mM EDTA  in PBS, 
washed in serum-free a- MEM, and resuspended in the same medium 
containing 1% FCS. Then cells were plated on fibmnectin-coated  slides and 
incubated for 6 or 12 h. After adhesion and spreading, nonadherent cells 
were removed  and the adherent cells were fixed for 15 min on ice with 0.5 % 
paraformaldehyde. After three washes with PBS, methanol was added for 
2 min, followed  by four more washes. Fixed cells were then incubated for 
30-40  rain with anti-/~l monoclonal antibody A-1A5 (1:400), antitalin 
monoclonal  antibody (1:.500  dilution of escites; Sigma  Immunochemicals), 
anti-hamster ws~ PB1 (1 #g/nil), or anti-P-Tyr  (1/~g/ml), then washed and 
incubated with FITC-labeled  goat anti-mouse antibody (1:40 dilution; Cal- 
biochem Corp.) for 35 rain. After staining, slides were washed with PBS 
four times and mounted. 
Proliferation Assays 
Cells were serum deprived by culturing in a- medium containing 1% FCS 
for 24 h, and then 50,000 cells were placed in the same solution, in 96-well 
plates coated with or without  different ECM proteins. Also, in some experi- 
ments, cells were preincubated with various antibodies for 15 rain before 
they were added to the 96-well plates. 
Proliferation was measured by pulsing the ceils with 1 #Ci [3H]thymi- 
dine/well during the last 8 h of  36-h culture. As a positive control, ceils were 
plated in the presence  of 10% FCS. A PHI) ceil harvester (Cambridge Tech- 
nology, Inc., Cambridge, MA) was used to transfer 3H-labeled DNA to 
glass fiber filters for analysis by liquid scintillation counting. 
Alternatively, cell proliferation was assessed using the MTT dye method, 
which detects mitochondriul enzymes (79). Briefly, during the last 4 h of 
36-h culture at 37°C, MTT (3-[4,5Mimethylthazol-2-yl]-2,5Miphenyltetra- 
zolium bromide) was added to each well to give 0.5 rag/rid. Then, after the 
ceils were solubilized in 0.01 N HCI containing 10% SDS for 8-12 h at 
37°C, OD at 650 minus 590 am was determined using a microplate reader 
(VMAx; Molecular Devices Co.). 
Results 
Expression of  Human ~i and {3vj cDNA in CliO Cells 
The expression of human/3t  and Bv~ cDNA in CHO cells 
was evaluated by flow cytometry as shown in Fig.  1. After 
selection  in  nucleoside-free  medium,  human  B~  and  Bt,5 
were expressed on CHO cells at comparable levels (column 
3) that were at least as high as the level of endogenous ham- 
ster  Bt  (column 2)  and  greater  than  the  level  of staining 
with  a  negative  control  antibody  (column  1).  After  am- 
plification in methotrexate followed by cell sorting, human 
/3~  and  Bt/5 were  homogeneously expressed  at high  levels 
(column 4)  10-fold greater than endogenous hamster/~  in 
the same cells (column 2). Mock-transfected CHO cells (top 
row)  expressed  endogenous  hamster  /~,  but  showed  no 
cross-reactivity with the and-human ~  antibody. Levels of 
hamster/35 did not change (column 5), but hamster of was 
expressed at equivalently higher levels on/3~-CHO and/3~,5- 
CHO cells compared to control CHO cells (column 6). Con- 
sistent with this, others have noted that/~t on CHO cells is 
predominantly associated with the of subunit (69). 
To  avoid  selection  for  anomalous  functional  traits,  no 
efforts were made to establish clonal cell lines. Instead, bulk 
cell  populations  amplified  for  /3t  or/3~/5  expression  were 
used  for all  subsequent  experiments,  along  with  untrans- 
fected or mock-transfected CHO cells. 
The human 81 and/3,/5 subunits expressed at the surface 
of CHO cells were further analyzed by immunoprecipitation 
from nonionic detergent  cell  extracts  of '~-labeled  cells. 
Polyclonal serum  to the/35  cytoplasmic domain immuno- 
precipitated  the 90-kD hamster/55  subunit  (lower arrow), 
presumably associated with hamster a v from/St-CHO, 8,,5- 
CHO and CHO-MTX cells (Fig. 2 A, lanes a-c). An addi- 
tional  band  corresponding  to  the  100-kD  chimeric  Bt/5 
chain was seen only from Bt,5-transfected cells (lane b, up- 
per arrow). As expected,  an antibody to the human B~ ec- 
todomain (A-1AS) coimmunoprecipitated associated/5 and a 
subunlts from B~ CHO (lane d) and B~/5-CHO cells (lane e), 
but  not  from  mock-transfected  (lane f)  or  untransfected 
CHO cells (not shown). The pattern of bands recognized by 
the  anti-human/3t  antibody  (lanes  d  and  e)  looked very 
similar  to the  of and/3~  bands  immunoprecipitated  from 
/~-CHO (lane g), B,5-CHO (lane h), and CHO-MTX (lane 
i)  by an antibody recognizing the cytoplasmic domain of 
hamster of.  These results are consistent with of being the 
predominant subunlt associated with human or hamster B~ 
on these cells. 
Immunoprecipitation from 35S-metabolically labeled/~,,5- 
CHO cells confirmed the presence of the B~,5 protein (Fig. 
2 B).  Antiserum to the B5 carboxy terminus recognized an 
extra band migrating similar to l~ (lane b, arrow) that was 
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Figure  I.  Flow  cytometric 
analysis  of CHO-MTX,  Bt- 
CHO,  and  Bt/5-CHO cells. 
Cells were stained with a neg- 
ative  control  antibody  (P3, 
column  1),  anti-hamster  B, 
(7E2, column 2), anti-human 
E.  (TS2/16,  columns  3  and 
4),  anti-hamster  /35  (IG8, 
column 5), or with anti-ham- 
ster  a 5  (B1E5,  column  6). 
Cells  in  columns  1-3  were 
stained after selection  for ~6 
wk in a- medium, but before 
methotrexate  amplification. 
Cells  in  columns  4-6  were 
analyzed after three cycles of 
methotrexate amplification. 
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from CHO cells. (.4) Extracts from nSI-labeled  cells were immu- 
noprecipitated using anti-/55 COOH-terminal polyclonal antiserum 
(lanes a, b, and c), anti-human/31 and mAb A-1A5 (lanes d, e, 
and f), and anti-tx5 COOH-terminal polyclonal serum (lanes g, h, 
and 0, and the resulting proteins were analyzed using nonreducing 
conditions. Cells were Bt-CHO (lanes a,  d,  and g),  Bt/5-CHO 
(lanes b, e, and h), and CHO-MTX (lanes c,f, and i). (B) Anti-B5 
COOH-terminal  polyclonal antiserum was used to immunoprecipi- 
tare 35S-labeled Bt-CHO cells (lane a),/~t/rCHO cells (lane b), or 
CHO-MTX cells (lane c). The mAb 1"3 was used for a negative 
control precipitation from CHO-MTX cells (lane d). Also, in two 
separate experiments, anti-human B~ mAb A-1A5 was used to 
precipitate integrins from ~l/rCHO (lanes e and g) and/3rCHO 
(lanes  fand h). Immunoprecipitated  proteins were analyzed using 
reducing (lanes a-d) or nonreducing conditions (lanes e-h). 
not seen in flt-CHO (lane a) or CHO-MTX cells (lane c). 
There was no evidence for o~  t,  ¢x  2,  &,  or a 6 subunits.  If 
present, these would have been seen as distinct bands under 
the reducing conditions used for lanes a-d. Also, two sepa- 
rate experiments showed that 35S-labeled BI" and B~,5-CHO 
cells  yielded  very similar  patterns  of  hummt/3 and hamster 
a subunits  (compare lanes  e and  f, g and h). These results 
are  consistent  with the  similar  human/~i and BI~5  expression 
levels  seen in Fig. I. 
Adhesive Properties of/3rCHO and/3vrCHO Cells 
The adhesion of/3t and/3t/5 CHO cells to fibronectin (Fig. 
3 A) was carded out both in the absence (parts a and b) and 
presence (parts c and d) of the PB1 antibody added to block 
background adhesion mediated by hamster tx5/31. In either 
case,  adhesion by 131 and/3~,5 CHO cells was greater than 
that seen by control (CHO-MTX) cells (parts a  and c), al- 
though the difference was more obvious when PB1 was pres- 
ent (part c).  When the anti-human /31  antibody 4B4 was 
added, adhesion by BI and B1/5 CHO ceils was no longer 
elevated compared to the CHO-MTX cells (parts b and d). 
The inhibitory effect of 4134 was especially obvious when 
PB1 was also present (part d). Thus, the substantial contri- 
butions of human/3~ and/~t/5 subunits to fibronectin adhe- 
sion were most obvious when the background contribution 
of hamster txs8~ was blocked. 
In contrast to fibronectin, collagen IV and laminin sup- 
ported only low levels of adhesion by the various CHO cells, 
and the adhesion by/~1- and B~,rCHO ceils was not sig- 
nificantly greater than adhesion by CHO-MTX cells (Fig. 3 
B, parts e and  f). These results are consistent with B~ being 
mostly associated with the hamster tx  5 subunit. Also, adhe- 
sion to vitronectin was essentially unchanged among CHO, 
/~-CHO,  and/~1/5-CHO  cells  (not shown),  indicating that 
the presence of the/~u5 chimera had no obvious effect on the 
adhesive function of hamster txv/35. 
In the presence of PB1 (anti-hamster txs/~m),  both/~I-CHO 
and/31/5-CHO  cells bound equally well to fibronectin in a 
dose-dependent fashion, markedly above the level of adhe- 
sion seen for mock-transfected (CHO-MTX) cells (Fig.  3 
B).  In  the  presence  of the  stimulatory anti-Bm antibody 
TS2/16,  adhesion of both By and/~m/rCHO cells was up- 
regulated to the same extent, especially at the lower doses 
of fibronectin. In addition, titration of Mg  2+ (from 0.005 to 
50 raM) revealed no significant differences between/31-  and 
Bl/5-dependent adhesion (Fig. 3 C). In summary, the results 
in Fig. 3 show that the/31  and/3L~5 subunits have a  similar 
level of constitutive activity, are equally responsive to stimu- 
lation by the anti-/~l antibody TS2/16,  and show equivalent 
use of Mg  2÷ to support adhesion. 
SubceUular Localization  of  /3v~ and/3~ in CHO Cells 
To compare the subcellular  distribution  patterns  of the/~i 
and/3~,5 subunits,  ~r and 131/5-CHO cells were plated for 
6-12 h on fibronectin. Then, after fixing and staining of per- 
meabilized cells with the anti-B1 antibody A-1A5 (specific 
to the extracellular domain), a very distinct distribution pat- 
tern was observed for the two cell lines (Fig. 4). Wild type 
human BI (Fig. 4, A,  (7, E, and G) consistently showed a 
punctate distribution pattern with many focal adhesion-like 
structures present.  In marked contrast,  /31,5 was diffusely 
distributed (Fig. 4, B, D, F,, and H) and not localized to focal 
adhesion-like structures in these and numerous other experi- 
ments.  Control experiments (Fig.  5)  showed that both BI- 
CHO ceils (A, C, and E) and/3t/5-CHO  cells (B, D, and F), 
had equal ability to form focal adhesions containing hamster 
¢xs/3t (weakly stained; A and B), talin (strongly stained; C 
and D) or phosphotyrosine (E and F). Antibody staining of 
nonpermeabilized cells or preincubation with antibody be- 
fore permeabilization also yielded striking differences in the 
localization patterns  of 131  and  •1/5,  with the latter being 
much more diffuse (not shown). These control experiments 
indicate that the diffuse staining seen for/3~/5 was not sim- 
ply caused by selective accumulation of that protein within 
intracellular pools. Also, endogenous wild type hamster/35 
remained diffusely localized in both Bt- and/31,5-CHO cells, 
consistent with the diffuse localization of/31,5. 
Contribution of  /3~ and [3~/j to CHO Cell Proliferation 
There have been several reports that integrins can deliver 
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Figure 3.  Comparison of adhesive properties of 
/31-CHO, /31/5-CHO, and  CHO-MTX cells.  (A) 
Plastic surfaces were coated with fibronectin,  col- 
lagen IV, or laminin (each at 5 #g/ml), and then 
cell adhesion assays were carried out as described 
in Materials  and Methods. The fibronectin  adhe- 
sion assays were carried out in the presence of  con- 
trol antibody, anti-human fll (4B4),  anti-hamster 
oP/31 (PB1),  or both 4B4 and PBI as indicated. 
(B) Adhesion to fibronectin  (coated  at 0.5, 2.0, 
and 10 ~g/ml) was carried out in the presence of 
2 #g/ml purified PB1 (to block hamster a5/3~ func- 
tion).  As indicated,  1/zg/ml of stimulatory anti- 
human ~  mAb TS2/16 was added for some as- 
says.  (C)  Adhesion to fibronectin  (coated  at  5 
t~g/ml) was carried out in the presence of varying 
concentrations of Mg  2+, and a constant level of 
PBI (2 #g/ml). 
costimulatory (15, 50) or direct stimulatory (53, 80) signals 
leading to cell proliferation. We hypothesized that the strik- 
ing differences in the subcellular localization properties of 
/3~ and/3,5 might correlate with differences in their contri- 
butions towards proliferation.  Thus, conditions were set up 
to examine the contribution of integrins towards prolifera- 
tion of CHO cells, exploiting the window of time (20-36 h) 
in which the CHO cells could maintain viability while be- 
Pasqualini and Hemler Distinct Functions of fh and [35 Cytoplasmic  Domains  451 Figure 4. Immunofluorescent localization of human/31 and/31/5 in CHO cells. The/3rCHO (leflpanels)  and/31/5-CHO cells (right panels) 
were allowed to attach and spread on fibronectin-coated slides for 6 h (A-D) or 12 h (E-H), and then were stained with anti-human/31 
mAb A-IA5 as described in Materials and Methods.  x900 (A and B),  x630 (C-F), or  x400 (G and H). 
The Journal of Cell Biology, Volume 125, 1994  452 Figure 5.  Immunofluorescent localization of hamster a5/~1, talin,  and phosphotyrosine in ~- and/~1/5-CHO  cells.  The ~-CHO (left 
pane/s) and ~/5-CHO cells (r/ght pane/s) were allowed to attach and spread on fibronectin-coated  slides for 6 h, and then were stained 
with anti-hamster a5~1 mAb PB1 (,4 and B), antitalin  polyclonal antiserum (C and D), or anti-phosphotyrosine antibody (E and F) as 
described in Materials and Methods.  × 630 (A-D) and  ×400 (E and F). 
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Figure  6.  Comparison of 
proliferative responses of fit- 
CHO  and  fit/s-CliO  cells. 
Serum-deprived  cells  were 
cultured  in the  presence  of 
different ECM proteins (first 
row under figure) and differ- 
ent  anti-integrin antibodies 
(second  row  under figure), 
and then proliferation was de- 
termined  by  pH]thymidine 
uptake measurements as de- 
scribed  in  Materials  and 
Methods. In a positive control 
experiment,  10%  FCS was 
added back to serum-starved 
cells.  * Proliferation by ill- 
CliO  cells  is  statistically 
greater  than  flt/s"CHO and 
CHO-MTX cells (P < 0.002, 
Student's  unpaired  t  tes0. 
• * Proliferation  by  fit-CliO 
cells in the presence of FN 
and  TS2/16  is  statistically 
greater compared to all of the 
other listed conditions (P < 
O.001,  Student's unpaired  t 
test). 
ing deprived of serum. As shown in Fig. 6, the combination 
of immobilized fibronectin plus  soluble TS2/16  caused a 
marked proliferation of serum-deprived fl~-CHO cells, but 
not fl~/5-CHO or control CHO-MTX cells, as measured by 
uptake of [3I-I]thymidine. Notably, neither fibronectin nor 
TS2/16 alone was sufficient. Also, the proliferative response 
to TS2/16 and fibronectin was not appreciably blocked by 
anti-hamster c~fl~ antibody PB1, indicating that fibronectin, 
like TS2/16,  was acting through the human fl~ subunit. In 
control experiments, a nonstimulatory anti-human fl~ anti- 
body (4B4),  the hamster asfl,  (PB1), and the control anti- 
body P3 had no stimulatory effect on proliferation, either 
alone or together with fibronectin. In the presence of 10% 
serum, transfeeted and control CHO cells all proliferated at 
a high level, with no detectable difference among them. 
Interestingly, intact fibronectin could not be replaced by 
the  120-kD  fibronectin fragment, even though it contains 
both the  central  o~fl~ binding  site  (the  RGD  region),  as 
well as a  second synergizing site of interaction with aSfll 
(54).  The requirement for intact fibronectin was not unique 
to CHO cells; a human B cell line (JY) and a myeloid cell 
line (KG1) also showed a similar fl~-dependent proliferation 
to intact fibronectin, but not to FN-40 or to FN-120 frag- 
ments (not shown). 
To further emphasize the proliferation difference between 
flt-CHO  and fl~/~-CHO cells,  the  results  of six  different 
[3H]thymidine uptake experiments are shown in Table I. In 
each  experiment,  the  proliferation of fit-CliO  cells  was 
markedly greater than Bt/~-CHO ceils in response to a com- 
bination of FN plus TS2/16. Such a difference was not obvi- 
ous if the cells were not stimulated or stimulated with FN 
alone.  To  complement the  pH]thymidine uptake  experi- 
ments,  we  also  carried  out proliferation experiments  by 
measuring cell viability using the MTT dye that detects mi- 
tochondrial enzymes (79). As shown in Table II in three sep- 
arate  experiments,  fl~-CHO  ceils  but  not fl~/s-CHO cells 
proliferated in response to a combination Of FN plus TS2/16. 
Consistent  with  results  in  Table  I  and  Fig.  6,  elevated 
proliferation by fl~-CHO cells was not obvious if the cells 
were not stimulated or stimulated with FN alone (Table ID. 
In general, MTT staining of CHO and fl~5-CHO cells was 
not diminished as a result of FN plus TS2/16 treatment, and 
fl~-CHO  and flt,5-CHO  cells  showed no  loss  of viability 
when those ceils were monitored by MTT staining before, 
Table L Proliferation of ill- and tim-CliO Cells 
Monitored  by [3H]Thymidine 
Experiment  No stimuli)  FN)  FN +  TS2/16¢  CHO-MTX 
1.  flrCHO  -  500  3,000  27,500  11,000" 
fll/5-CHO  -200  3,200  2,400  " 
2.  fl,-CHO  -  140  2,500  30,600  10,500 
flii~-CHO  -  180  2,000  2,800 
3.  ill-CliO  1,500  4,600  I0,000  13,700 
fll/~-CHO  2,400  3,200  5,500  " 
4.  fl1-CHO  -200  3,800  25,000  12,000 
fl,/5-CHO  -5,800  1,400  1,600  " 
5.  ill-CliO  1,100  1,600  19,600  10,150 
ilia-CliO  -  3,400  2,600  -  1,800  " 
6. flrCHO  1,100  2,300  7,500  8,700 
fl]/~-CHO  1,600  1,200  2,900  " 
* All numbers represent cpm of [3H]thymidine and are the mean of six deter- 
minations. 
$ Background  values  for  [3H]thymidine uptake  by mock-transfecmd  CHO- 
MTX cells (last column) are subtracted from all values shown in the first three 
colunms. Serum-deprived  cells were grown in the presence of immobilized 
fibronectin and in the presence or absence of soluble TS2/16,  and proliferation 
was determined as described in the Materials  and Methods. 
The Journal  of Cell Biology,  Volume 125, 1994  454 Table II. Proliferation of fir and f3~/z-CHO Cells 
Monitored by MTT Staining 
Experiment*  No stimuli*  FN*  FN  +  TS2/16~ 
1.  CHO-MTX  0.24  0.13  0.29 
ill-CliO  0.19  0.27  1.11 
flt:s-CHO  0.27  0.21  0.24 
2.  CHO-MTX  0.38  0.40  0.34 
fll-CHO  0.41  0.29  1.27 
fll/5-CHO  0.31  0.39  0.18 
3.  CHO-MTX  0.34  0.39  0.23 
flrCHO  0.31  0.35  0.98 
fll/s-CHO  0.39  0.26  0.24 
* In each experiment, cells were serum-deprived for 24 h and then cultured for 
26 h  in the presence or absence of immobilized FN and soluble TS2/16 as 
described (see Materials and Methods). 
All numbers represent OD570~0 values indicative of MTT staining of viable 
cells (see Materials and Methods), and they are the mean of triplicate  determi- 
nations. 
during, and after a 32-h interval of serum deprivation (not 
shown). Thus, the proliferation differences observed in Fig. 
6 and Tables I and H were not caused by selective apoptosis. 
Specific Phosphorylation of a 90-kD Protein 
in fll CHO Cells 
The same conditions that caused a difference in proliferation 
between  ~I-CHO  and  ~us-CHO  cells  also yielded an obvi- 
ous  biochemical  difference.  The  /~:CHO  and  fl~/5-CHO 
cells were stimulated with fibronectin and TS2/16 while in 
the presence of [32p]orthophosphate, and  then whole cell 
extracts were prepared in the presence of  phosphatase inhibi- 
tors  and  analyzed by SDS-PAGE.  Whereas  several phos- 
phoproteins were present  in  both  /3t-CHO  and  /~/5-CHO 
cell extracts, a 90-kD phosphoprotein band was present only 
in the extract from fl:CHO cells (Fig. 7). Using a common 
95-kD phosphoprotein as an internal standard, gel scanning 
confirmed that the p90 was prominent in fl~-CHO  cell ex- 
tracts,  but almost undetectable in  extracts  from fl~:5 cells 
(Fig.  7), CHO cells, or CHO-MTX cells (not shown). 
In several additional experiments, the specific appearance 
of the pg0 phosphoprotein showed a strong correlation with 
cell proliferation (Table HI).  Under  conditions  of serum 
deprivation, the p90/p95 ratio was elevated for ~-CHO but 
not  fl~/5-CHO cells,  and  only when  both  fibronectin and 
TS2/16 were present at the same time. In contrast to TS2/16, 
an  anti-fl~ antibody  not  able  to  stimulate  cell  adhesion 
(4134) did not costimulate (with fibronectin) the appearance 
of either p90 phosphoprotein or proliferation. Under normal 
growth  conditions  (10%  serum),  both  proliferation  and 
elevated pg0 expression were observed. In summary, the ap- 
pearance of pg0 is closely associated with cell proliferation 
and  provides an  independent readout consistent  with  the 
selective involvement of/3~ but not fl~:5 in cell proliferation. 
Migration on Fibronectin 
The o:fl~ integrin has a well-established role in cell migra- 
tion on fibronectin. Thus,  to further investigate the func- 
tional  properties  of the  fl~- and  flt~5-CHO cells,  we used 
modified Boyden chambers containing 8.0 #m porous mem- 
branes to analyze cell migration.  In the presence of PB1 
(added to block the adhesion of endogenous hamster astir) 
Figure 7. Induction of phosphorylation of a 90-kD protein in ~- 
CHO cells, fli-CHO or fl~/5-CHO  cells were plated on fibronectin 
(coated at l0 #g/ml) for 3 h, in the presence of 1 #g/ml TS2/16, 
and  1 mCi  [32p]orthophosphate (200 #Ci/ml,  carrier free;  New 
England  Nuclear)  per  100-mm dish  in  phosphate-fre~  DME 
medium. Cell extracts were prepared in the presence of 200 mM 
sodium vanadate and fractionatexi  by SDS-PAGE, as shown in the 
left panel. Also, the lanes were scanned using a densitometer as 
shown in the right panel. 
Table IlL  Correlation  between pgO Phosphorylation and 
ill- ClIO Proliferation 
Growth  pg0/p95 
Condition  Cells  ratio  Proliferation* 
1%  S  flrCHO  0.08  - 
fll/5-CHO  0.11  - 
1%  S;  TS2/16  fl~-CHO  0.19  - 
fll/s-CHO  0.14  - 
1%  S;  TS2/16;  FN  fll-CHO  0.65  + 
fll/5-CHO  0.12  - 
1%  S; 4B4;  FN  fl~-CHO  0.08  - 
fll/5-CHO  0.12  - 
10%  S  ill-CliO  0.72  + 
Bl/5-CHO  0.68  + 
* Proliferation of fl~-CHO and flus-CHO cells was determined as described in 
the legend for Fig. 6.  +, >  lO-fold  greater fl~ proliferation compared to 81/5 
after  subtraction of CHO-MTX background;  -,  less than twofold  greater 
proliferation for flrCHO cells. 
* Ratios of the levels of phosphorylated p90 relative to p95 were based on 
peak areas obtained from gel scans such as shown in Fig. 7. 
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Figure 8.  Haptotactic  migration of CHO, /3t-CHO and/~t/s-CHO 
cells.  As described  in Materials  and  Methods,  [35S]methionine- 
labeled cells were placed into the upper compartment of a modified 
Boyden chamber in the presence  of mAb PB1 (to block hamster 
ctsflt function).  (A) After 6 h, all radioactivity  on the upper sur- 
face of  the membrane was removed by extensive washing, and then 
radioactive cells that had traversed the membrane towards the bot- 
tom surface were quantitated. The bottom surface was coated with 
fibronectin, vitronectin,  or pronectin  (or nothing),  and in two ex- 
periments,  1/~g/ml of TS2/16 was also included. (B) Migration to- 
wards fibronectin was carded out in the presence of  0.1% FCS, 10% 
FCS, 0.1% FCS plus  100 nM PMA,  or 0.1% FCS plus 40 ng/ml 
PDGF (Promega Biotec) as indicated. In one experiment, the bot- 
tom surface was coated with collagen and migration was carried out 
in 10% FCS. (C) Migration towards fibronectin,  in the presence 
of TS2/16, was determined at the indicated time points using condi- 
tions described in (A). Background migration displayed by CHO- 
MTX control cells was subtracted. These background values were 
65,000,  58,000, 48,000, and  129,000 cpm at  1,  6,  8,  and  12 h, 
respectively. 
$~-CHO  cells  showed  only  background  cell  motility  to- 
wards fibronectin, vitronectin, pronectin,  and towards sur- 
faces not  specifically coated with any matrix protein.  Be- 
cause the migration of/31-CHO cells was not significantly 
elevated or depressed compared to untransfected or mock- 
transfected CHO cells (Fig.  8 A), human/3,  did not appear 
to  exert either  a  positive or  negative  effect on  CHO  cell 
migration.  In contrast,  /3~/5-CHO cells displayed markedly 
increased migration toward a fibronectin source (Fig. 8 A), 
and even a higher level of migration in the presence of the 
anti-/~  stimulating antibody TS2/16.  The presence of TS2/ 
16 alone had no effect on cell migration if ECM protein was 
omitted.  In separate experiments, cells crossing the mem- 
brane towards the lower compartment were counted by mi- 
croscopic examination, yielding data comparable to that ob- 
tained using 35S-labeled cells (not shown). The difference in 
migration between ~rCHO and ~/5-CHO cells was main- 
tained for t>12 h  (Fig.  8  C).  These results point to a pro- 
nounced difference in the contribution of the ~5 and ~  cy- 
toplasmic domains towards cell migration. 
Analysis of additional  experimental conditions  revealed 
that migration of flt/5-CHO cells was markedly elevated in 
the presence of 10% serum, compared to 0.1%  serum (Fig. 
8 B).  This serum effect could not be mimicked by adding 
PMA or PDGE Also, the presence of 10%  serum did not 
support nonspecific migration when a control ligand (colla- 
gen) was used. 
Discussion 
The central finding in this paper is that the/31  and 85 cyto- 
plasmic domains were equally able to support cell adhesion, 
but showed marked differences in multiple postligand bind- 
ing functions. Whereas the/3, cytoplasmic domain was bet- 
ter suited for localizing into focal adhesion-like structures, 
and selectively contributed to cell proliferation (associated 
with  p90  phosphorylation),  the  /35  cytoplasmic  domain 
facilitated migration of CHO cells on fibronectin. 
Differences in SubceUular Localization 
Previously,  it  was  found  that  o~v/35 and  t~"/33 had  different 
subcellular distribution patterns in cells spread on vitronec- 
tin (82), but it was not shown that the/3 chain cytoplasmic 
domains  were responsible.  Here,  we provide explicit evi- 
dence that replacement of only the cytoplasmic domain of 
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Figure 9. Comparison of the human/~5 (51, 61, 77) and ~1 (2) cy- 
toplasmic domains. Residues important for focal adhesion forma- 
tion are shaded (64), residues of likely importance for adhesion 
regulation  are boxed (31),  and noneonservative  differences be- 
tween B1 and B5 are indicated by the dashes below. 
8|  with that  of/35 was sufficient to alter dramatically  the 
subcellular  distribution  of  the  integrin  towards  a  more 
diffuse state. 
Approximately 10 key residues within the 8| cytoplasmic 
domain have been identified that determine whether 8t will 
localize  to  focal  adhesions  or  will  be  distributed  more 
diffusely (64).  Three of these residues in 8| (Fig.  9, posi- 
tions 28,  35,  and 38) are missing  in Bs, thus perhaps  ex- 
plaining why 85 fails to localize to focal adhesions. Related 
to this, the same three 8| residues (positions 28, 35, and 38) 
occur within a potential ot-actinin binding region (57) that 
may be important for focal adhesion formation. Attention is 
now also focused on the 10 additional residues that make 85 
longer  than  ~1  (Fig.  9),  which  could potentially  exert  a 
negative effect. 
Similarities in Cell Adhesion 
The 8,  and 8~/5 subunits made virtually identical contribu- 
tions towards CHO cell adhesion regardless of fibronectin 
levels  or  divalent  cation  levels,  and  both  were  equally 
responsive to stimulation by an anti-81  activating antibody 
(TS2/16).  Because of these  nearly  identical  cell adhesion 
results, we consider it highly likely that the differences we 
observed in other functions  were not simply caused by a 
gross alteration of the overall integrin structure. Even more 
importantly, the inside-out signaling mechanisms regulating 
the  constitutive  adhesive  activity  of 8~  integrin  in  CHO 
cells appear to be independent of the mechanisms regulating 
subceilular localization, cell migration, or cell proliferation. 
This leads to an important  qualitative distinction between 
the type of integrin clustering that may facilitate cell adhe- 
sion in a  short-term assay of 0.5-1 h  (30) and the integrin 
clustering that is visible in focal adhesions after 6--12 h. 
Key residues within the B2 (31)  and 83 (12) cytoplasmic 
domains have been identified that are involved in the regula- 
tion of integrinqigand  adhesive interactions.  For the most 
part, those residues are conserved in both 8~ and 85 (Fig. 9, 
positions 30-32, 38, 39) if you allow the phenylalanine at po- 
sition 39 in 85 to substitute for the Tyr at position 38 in 8~. 
Thus,  a  common  mechanism  for  controlling  cell  adhe- 
sion/ligand binding appears to be shared by multiple integrin 
/3 subunit  tails,  even though  they may differ markedly  in 
other functional respects. 
Differences in Cell Proliferation 
A large body of literature (reviewed in references 33 and 46) 
has addressed the effects of fibronectin and other ECM pro- 
teins on cell proliferation.  These ECM proteins act at least 
partially through integrins, because many integrin ligands or 
anti-integrin  antibodies  had  costimulatory  effects on  cell 
proliferation (15, 50, 55, 66, 73, 85). Although a few studies 
have  suggested  that  mitogenesis  can be achieved directly 
through  integrins  (53, 78,  80), most studies have failed to 
sort out direct proliferative signals from other events such as 
integrin-mediated cell adhesion, shape change, and potentia- 
tion of other growth triggering agents. Our results now pro- 
vide a  clear demonstration  that the 81 and 85 cytoplasmic 
domains  differ markedly  in their  ability  to influence  cell 
proliferation,  even though they support cell adhesion to a 
similar extent.  We hypothesize that the ability of 8~ to be 
recruited  more  readily  into  macromolecular  subcellular 
structures could facilitate signaling required for cell prolifer- 
ation.  Conversely,  the more diffuse localization  of the 85 
cytoplasmic domain might prevent molecular associations 
needed for proliferation.  In this regard,  subcellular struc- 
tures such as focal adhesions are increasingly seen as sites 
of signaling,  where relevant cytoskeletal proteins and other 
proteins may become exposed to kinases and/or phospha- 
tases (24, 34, 38, 48). 
We consider  it  unlikely  that  the  observed proliferation 
differences are caused by an alteration in the pattern of as- 
sociated ct chains between/31 and 81/s because (a) the major 
ot subunit associated with 81 on CHO cells (i.e.,  ot  s) was 
expressed at identical levels in 8|- and 8vs-CHO cells; (b) 
both 8~ and 8|/5 yielded identical immunoprecipitation pat- 
terns; and (c) there was no evidence for other 8|-associated 
chains, based on negative collagen and laminin adhesion 
assays  and  immunoprecipitation  results.  Furthermore,  all 
available evidence indicates  that integrin  or8 pairing  spec- 
ificity is determined by extracellular (and perhaps also trans- 
membrane),  but  not  cytoplasmic  domains  (5,  6,  14,  20, 
56, 74). 
Because both TS2/16 and intact fibronectin together were 
required  to trigger  proliferation  of 81-CHO cells,  we hy- 
pothesize  that  TS2/16  strengthens  the  affinity of otsB| for 
fibronectin (as previously described [3,  8,  19, 81]) thus al- 
lowing  the  integrin,  along  with  proteins  interacting  with 
other domains in the intact fibronectin, to be gathered into 
the appropriate membrane-spanning signaling complex. Al- 
ternatively,  the anti-8|  antibody itself could be sending  a 
costimulatory  signal  that  acts  synergistically  with  intact 
fibronectin,  but not fibronectin fragments or peptides. 
In the many previous studies showing cell proliferation as 
a result of costimulatory signals acting through 8~ integrins 
(10,  15, 50, 55, 73, 85), it was often not clear whether the 
contribution of the 8| integrin went beyond simply provid- 
ing cell adhesion. Our results now indicate clearly that adhe- 
sive capability alone is not sufficient (such as in 8~5-CHO 
cells), and that the 8~ cytoplasmic domain is serving addi- 
tional  signaling  and/or  localization  functions  required  for 
cell proliferation. 
The nearly all-or-none appearance of phosphorylated p90 
in response to fibronectin plus TS2/16 showed a strong corre- 
lation with enhanced cell proliferation.  At the present time, 
we cannot determine whether this event is an essential part 
of the downstream signaling pathway leading to proliferation 
or part of a divergent pathway. We suspect that p90 is phos- 
phorylated on serine or threonine because it was readily de- 
tected at a high level in a whole cell extract, and it was not 
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teins of ~90  kD,  such as HSP-90  (84),  PKC-e  (67),  and 
pp90  ~sk (11), that are phosphorylated on serine or threonine, 
pp90  ~k has the most obvious association with cell prolifera- 
tion (11). However,  we found no difference in the level of 
phosphorylated pp90  rsk immunoprecipitated from/3t-CHO 
and/31/5-CHO  cells, regardless of the stimulation of those 
cells with fibronectin and TS2/16 (not shown). Thus at pres- 
ent, the identity of our p90 protein is unknown. Nonetheless, 
its phosphorylation is closely correlated with cell prolifera- 
tion, and it provides an independent assay indicating that the 
/3~ tail has a unique signaling function not seen with the ~5 
tail. 
Differences in Cell Migration 
We hypothesize that differences between the fl~ and/35 cyto- 
plasmic domains with respect to subcellular localization are 
likely to be closely associated with differences in cell migra- 
tion. For example, the/~5 cytoplasmic domain, by promot- 
ing more diffuse subcellular localization, could thus facili- 
tate cell migration. In this regard, others have also noted an 
inverse correlation between focal adhesion formation and 
cell motility (1,  17, 63). Although c~5/3t can have a negative 
effect on random cell migration when overexpressed in CHO 
cells (22),  our/3,-CHO cells did not migrate any less than 
untransfected or mock-transfected CHO cells in a haptotac- 
tic migration assay.  Thus, rather than the/3~  tail having a 
negative effect,  the  /35  cytoplasmic domain  seems  to  be 
playing a positive role. 
In the complex multistep process of cell migration, we 
propose that/31 and/31/5 may not differ in the initial adhesive 
steps that are required, but rather, they may show critical 
differences in a later step involving integrin-cytoskeletal in- 
teractions at the leading edge of the cell (68).  Alternatively, 
considering that the/3~/~-CHO cells were more migratory 
than /~I-CHO cells only when serum was present,  the ~5 
and/3t cytoplasmic domains may differ in their abilities to 
translate signals resulting  from serum  stimulation into a 
migratory phenotype. Another possibility is that processes 
such as phosphatase-dependent deadhesion, also known to 
influence cell motility (29),  could differentially act on ~/~ 
and/35  cytoplasmic domains. 
While the precise biochemical mechanism by which the 
~5 cytoplasmic tail facilitates migration remains to be de- 
termined, we do not wish to imply that the t5 tail is never 
able to form focal adhesion-like structures during cell migra- 
tion, especially since the transient occurrence of such struc- 
tures may be an essential step in cell migration (62).  Rather, 
we simply propose that the/35 tail has properties that make 
it averse to localization into focal adhesions in highly spread 
cells,  but  at the  same  time,  contribute to  enhanced cell 
migration. 
The independent regulation of cell adhesion and migration 
has also been observed in studies involving integrin c¢ chain 
cytoplasmic domains. Whereas the od, od, and ot  5 cytoplas- 
mic domains contributed similarly to cell adhesion (9, 39, 
41),  the od cytoplasmic domain was more effective at sup- 
porting migration (9). 
In another study,/33 but not/35 supported cell migration, 
even though the latter was more diffusely distributed (44), 
thus contrasting with the results shown here.  Possibly /~s 
did not support migration in the previous study because se- 
rum was not present, a different cell type was used (a pan- 
creatic carcinoma) or a different c~ chain (a  v) was involved 
(44). 
In conclusion, our results  support a  general scheme in 
which different integrins use commonly shared mechanisms 
to control cell adhesion (inside-out signaling), but translate 
adhesive information into  sharply contrasting subsequent 
events (outside-in signaling), depending on the unique fea- 
ture of their different cytoplasmic domains. Thus, we predict 
that other/3 subunits with even more divergent cytodomains 
(/36,/38, and/34) will differ from/~1 and/35 in several of the 
same parameters examined here. In addition, our results be- 
gin to suggest how subcellular localization of integrins could 
exert control over diverse functions such as cell proliferation 
and cell migration. The challenge in the future will be to 
identify specific biochemical associations for H1 and/35 cy- 
toplasmic domains that are relevant to their specific func- 
tions. 
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